SAMC
SCLN

Shinko Asset Management Company’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Shinko Asset Management Company’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.28M Sell
222,827
-101,824
-31% -$1.11M 0.02% 176
2016
Q2 		$4.24M Sell
324,651
-134,956
-29% -$1.77M 0.03% 104
2016
Q1 		$5.06M Sell
459,607
-25,241
-5% -$224K 0.04% 92
2015
Q4 		$4.46M Buy
484,848
+86,422
+22% +$723K 0.04% 105
2015
Q3 		$2.77M Buy
+398,426
New +$3.41M 0.03% 136

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shinko Asset Management Company's SCLN Position: Q3 2016 in Review

Shinko Asset Management Company reduced its Sciclone Pharmaceuticals Inc (SCLN) stake by 31% in Q3 2016, selling an estimated $1.11M and leaving 222,827 shares worth $2.28M. The position accounts for 0.02% of the portfolio, ranked #176.

Shinko Asset Management Company first reported a position in SCLN in Q3 2015 and has held it in 5 quarters since. The position peaked at $5.06M in Q1 2016. 151 funds tracked by Wall St. Rank hold SCLN as of Q3 2016.

  • Shinko Asset Management Company held 222,827 shares of Sciclone Pharmaceuticals Inc worth $2.28M as of Q3 2016.
  • Shinko Asset Management Company sold 101,824 Sciclone Pharmaceuticals Inc shares in Q3 2016, an estimated $1.11M.
  • Sciclone Pharmaceuticals Inc made up 0.02% of Shinko Asset Management Company's portfolio in Q3 2016, its #176 holding.
  • Shinko Asset Management Company first reported a position in Sciclone Pharmaceuticals Inc in Q3 2015 and has held it in 5 quarters since.
  • Shinko Asset Management Company's Sciclone Pharmaceuticals Inc position peaked at $5.06M in Q1 2016.
  • 151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.